Beyond the Score: Fixed-Budget Benchmarking of Virtual Screening Integration Strategies for Decision-Centric Drug Discovery
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27167497 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Elisabetta Grazia Tomarchio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy. Hauptthemen laut MEDLINE: Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Fondazione ICSC Centro Nazionale di Ricerca in High Performance Computing, Big Data e Quantum Computing, Italian Ministry of Health.
Abstract (Originalsprache)
Virtual screening (VS) workflows often combine structure- and ligand-based methods; however, their value depends on the number of compounds that can be tested. We benchmarked 20 fixed-budget strategies derived from molecular docking (GNINA CNN score), maximum common substructure (MCS) similarity, and a calibrated machine-learning (ML)-QSAR classifier across five pharmacologically diverse targets. Individual methods, best-rank and worst-rank fusion, mean-rank consensus, and sequential funnels were evaluated at 1%, 5%, and 10% library fractions, with every strategy selecting the same number of compounds. ML-QSAR was the strongest standalone method, recovering 47.6%, 81.6%, and 84.4% of actives at the three cutoffs. At the 1% budget, ML-QSAR achieved the highest mean hit recovery (47.6% recall; 99.2% precision). At 5% and 10%, best-rank fusion of QSAR and MCS produced the highest mean recall (83.2% and 86.4%). Among the sequential workflows, QSAR → MCS achieved the highest 1% hit recovery (45.2 ± 3.3% recall), whereas docking-first funnels consistently underperformed under the default, non-optimized conditions evaluated in this study. Target-level results showed substantial variability in MCS-containing workflows and limited benefits from adding docking without target-specific optimization. Under matched assay budgets, a validated ligand-based predictor or a simple two-method rank-fusion scheme provided the highest observed mean hit recovery without requiring elaborate integration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy.
- Department of Biomedical and Biotechnological Sciences, University of Catania, Via Santa Sofia 97, 95123 Catania, Italy.
ORCID-Profile: Elisabetta Grazia Tomarchio, Rocco Buccheri, Antonio Rescifina
Förderung
- Ministry of Health
- Fondazione ICSC Centro Nazionale di Ricerca in High Performance Computing, Big Data e Quantum Computing
- Italian Ministry of Health
Zitieren
APA
Tomarchio, E. G., Buccheri, R., & Rescifina, A. (2026). Beyond the Score: Fixed-Budget Benchmarking of Virtual Screening Integration Strategies for Decision-Centric Drug Discovery. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27167497
Vancouver
Tomarchio EG, Buccheri R, Rescifina A. Beyond the Score: Fixed-Budget Benchmarking of Virtual Screening Integration Strategies for Decision-Centric Drug Discovery. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27167497
BibTeX
@article{Tomarchio2026,
author = {Tomarchio, Elisabetta Grazia and Buccheri, Rocco and Rescifina, Antonio},
title = {Beyond the Score: Fixed-Budget Benchmarking of Virtual Screening Integration Strategies for Decision-Centric Drug Discovery},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27167497}
}
EUVIMED